ISOP_Logo_Final
+1-908-253-3608
info@go-isop.org
Facebook
Twitter
LinkedIn
YouTube
  • About ISoP
    • Constitution and By-laws
    • Five-Year Strategic Plan
    • Leadership Team
    • Awards
    • ISoP Fellows
    • Member Spotlight
    • Logo Usage Policies
    • Communications Guidelines
    • Memorial Policy
    • discuss.go-isop.org
    • Photo Gallery (Flickr)
    • Contact Us
  • Events
    • ACoP
    • PAGE
    • WCoP
    • AAPS
    • ACCP
    • ASCPT
    • PAGANZ
    • PAGJA
    • Pharmacometrics Network Benelux
    • PKUK
    • RedIF
    • SUP
  • Membership
    • Member Profile
    • Join
    • Renew
    • Volunteer
  • Training Material
    • Tutorials
    • ISoP YouTube Channel
    • Shiny Server
    • Resources
  • SIGs
    • Clinical Pharmacometrics
    • Mathematical and Computational Sciences (MCS)
    • Quantitative Systems Pharmacology (QSP)
    • Statistics and Pharmacometrics (SxP)
  • Committees
    • Awards Committee
    • Communications Committee
    • Conference Committee
    • Diversity Equity & Inclusion (DE&I) Committee
    • Education Committee
    • Executive Committee
    • Finance Committee
    • Membership Committee
    • Nominations Committee
    • Scientific Partnership Committee
    • Standards & Best Practices Committee
    • Technology Committee
  • Trainee Community
  • Local Groups
    • Midwest
    • New England
    • NJ/PA/NY
  • Official Journals
    • Recent Publications
    • Newsletters
  • Career Center

Mathematical and Computational Sciences SIG

Home Special Interest Groups (SIGs) and Communities Mathematical and Computational Sciences SIG

Mission

The MCS SIG is a forum for ISoP members sharing common interests in
advancing mathematical and computational techniques in pharmacometrics.
Our goals include increasing awareness within the ISoP community of
existing or emerging MCS methods, offering training in their use, and
providing guidance for rigorous and impactful applications. We also
maintain ties with mathematical communities around the world to promote
pharmacometrics as a scientific discipline generating a variety of
interesting theoretical and applied problems.

Objectives

The activities of the MCS SIG are focused on the following themes:

  1. Networking: increase ties between the broader MCS community and
    pharmacometrics including other SIGs; provide venues for learning and
    collaboration.
  2. Learning: act as a resource for the pharmacometrics community,
    including students, through recommended reading, courses, conference
    sessions, and online discussions and materials.
  3. Collaboration: help identify and publicize existing MCS methods for
    pharmacometrics needs; promote opportunities for MCS researchers to
    develop new theories, methods, and computational tools.

Leadership Team

Gilbert Koch (Chair)
 

Dr. Gilbert Koch is an interdisciplinary scientist with mathematical background. Currently he works as Senior Research Fellow in the Pediatric Pharmacology and Pharmacometrics Group at the University Children’s Hospital in Basel, Switzerland. Additionally, he holds an Adjunct Assistant Professor position at the University of New York at Buffalo, NY, USA.

Dr. Koch’s interests are pediatric and rare disease related optimal drug dosing questions, modeling of drug-drug interaction at various levels, advanced mathematical modeling techniques such as delay differential equations, mathematical rigorous optimization approaches to compute optimal dosing regimens, target-mediated drug disposition models with more drugs and more targets, and finally development of decision support tools to assist clinicians in daily practice. His PhD was sponsored by Nycomed (now Takeda) and his PostDoc at the University at Buffalo, NY, was funded by Fonds National de la Recherche Luxembourg, Marie-Curie Action.

Craig Thalhauser (Vice Chair)
 

Dr. Craig Thalhauser is a mathematician and currently holds the position of a Director, Quantitative Systems Pharmacology (QSP) at Genmab. He received his Ph.D. in mathematics from Arizona State University after an M.S. in Cellular and Molecular Physiology from Tufts University. His work since the start of his postdoctoral fellowship has been to apply mathematical models to questions of biology to generate new hypotheses about the dynamics of a process or disease.

Prior to joining Genmab, Dr. Thalhauser was a Research Fellow in the Quantitative Clinical Pharmacology group at Bristol-Myers Squibb, where he led QSP efforts in autoimmune disease drug development. Prior to BMS, he was a mathematical modeler at Immunetrics, Inc, a biosimulation CRO specializing in QSP model development in inflammation.

Peiying Zuo (Secretary)

Peiying Zuo is a Director in the Pharmacometrics US group at Astellas Pharma. She received her Ph.D. in applied mathematics with a concentration in molecular and cellular biophysics from the University of North Carolina in Chapel Hill.  After 8 years in the clinical pharmacology group at GSK and 1.5 years at PAREXEL, Peiying joined Astellas in 2016, supporting application of model-based drug development (MIDD) primarily in oncology and immune-oncology. With experience across numerous therapeutic areas and in all drug development phases, her areas of expertise include concentration-QT analyses, modeling in viral dynamics and immuno-oncology, population PK in pediatrics, and more recently PKPD modeling for antibody-drug conjugates (ADC). Outside her work, Peiying is currently involved in the Innovation & Quality (IQ) Consortiums for ADCs and COVID-19. She is also an enthusiastic member and officer in the Astellas Toastmasters club. 

Steering Committee Members

  • Dean Bottino
  • Jeroen Elassaiss-Schaap
  • Denise Kirschner
  • Ami Radunskaya
  • Wojciech Krzyzanski
  • Helen Moore
  • Carl Panetta
  • Johannes Schropp
  • Tongli Zhang
  • Peiying Zuo
  • Justin Wilkins, ex officio

Elections

Elections are held once per year. The Vice Chair assumes the role of Chair and the Secretary assumes the role of Vice Chair when those respective positions are vacated.

Our other home on the web

Visit our homepage here for news and updates on our activities.

Join Us

Are you interested in receiving updates and participating in SIG discussions? Join the ISoP MCS SIG today, click here.

     
What’s New
  • Upcoming Webinars February 22, 2023
  • Introducing ISoP President-Elect: Vijay Ivaturi, Ph.D. November 30, 2022
  • Meet ISoP Member Michelle Johnson July 5, 2022
ISoP Membership
  • Join Now
  • Benefits
Copyright 2021 by ISoP
Privacy Statement

International Society of Pharmacometrics
1200 Rt 22E Suite 2000
Bridgewater, NJ 08807
United States

+1-908-253-3608
info@go-isop.org
@ISoP1